Patients with high PD-L1 in tumor and low PD-L1 on TILs (as opposed to low PD-L1 in tumor and high PD-L1 on TILs) had the worst prognosis, therefore they could be candidates for novel treatment approaches. Here, CD274 is linked to neoplasm.